Advanced Medical Equipment

Neovasc Inc announces application to list on NASDAQ

Neovasc Inc:Applies to list common shares on NASDAQ Capital Market.Such listing is dependent upon company meeting all of necessary listing requirements of Nasdaq.

Thursday, 17 Apr 2014 06:17pm EDT

Cepheid reaffirms FY 2014 revenue guidance; lowers FY 2014 EPS guidance

Cepheid:Says reflecting issuance of convertible senior notes in Feb 2014, it has updated it's guidance for FY 2014.Expects FY 2014 total revenue in the range of $446 to $461 million.Expects FY 2014 net loss in a range from $(0.43) to $(0.38) per share.Expects FY 2014 non-GAAP net income in the range...

Thursday, 17 Apr 2014 04:05pm EDT

Theraclion raises 10.9 million euros in IPO

Theraclion SA:Raises 10.9 million euros in IPO.Issues 750,120 shares at 14.50 euros each.In addition 155,063 new shares were issued as a result of conversion of 14,000 bonds.

Thursday, 17 Apr 2014 12:33pm EDT

Olympus to dissolve Olympus Biotech International

Olympus Corp:To dissolve a wholly owned subsidiary Olympus Biotech International Ltd. in Ireland, which has been engaged in sale of biological material products, and complete liquidation in 2017.

Thursday, 17 Apr 2014 03:30am EDT

Expansion & New Markets

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00
Provider: Renaissance Capital
$92.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.